Valuation: Haleon plc

Market Cap 33.55B 44.64B 39.17B 36.48B 62.9B 4,265B 63.98B 433B 169B 2,115B 168B 164B 7,307B P/E 2026 *
19.7x
P/E 2027 * 17.8x
Enterprise Value 40.47B 53.84B 47.25B 44B 75.86B 5,143B 77.16B 522B 204B 2,551B 202B 198B 8,813B EV / Sales 2026 *
3.55x
EV / Sales 2027 * 3.36x
Free-Float
99.42%
Yield 2026 *
2.1%
Yield 2027 * 2.33%
1 day-0.28%
1 week+4.10%
Current month+9.55%
1 month+9.33%
3 months+12.03%
6 months+2.50%
Current year+1.63%
1 week 358.4
Extreme 358.4
384.2
1 month 347.7
Extreme 347.7
384.2
Current year 317.8
Extreme 317.8
416.1
1 year 274.4
Extreme 274.4
416.1
3 years 274.4
Extreme 274.4
419.5
5 years 241.17
Extreme 241.1735
419.5
10 years 241.17
Extreme 241.1735
419.5
Manager TitleAgeSince
Chief Executive Officer 59 2021-07-21
Director of Finance/CFO 57 2024-10-31
Chief Tech/Sci/R&D Officer 63 2025-07-31
Director TitleAgeSince
Director/Board Member 59 2022-05-22
Chairman 71 2025-12-31
Director/Board Member 59 2022-07-17
Date Insider Type Main position Quantity % Market Cap.
6/30/26 Free

Chief Financial Officer

283,193 0.0032%
6/30/26 Tax

Chief Financial Officer

-133,301 0.0015%
5/19/26 Buy 24,891 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-0.33%+4.10%+3.73%+13.26% 44.64B
+1.93%+3.85%+51.05%+166.24% 1,089B
+0.29%+6.43%+60.47%+52.87% 643B
+2.45%+2.77%+39.61%+74.48% 465B
-0.03%+11.16%+42.39%+36.55% 359B
+0.22%+4.56%+38.37%+43.91% 303B
+1.00%+3.21%+17.49%+17.20% 267B
-0.40%+4.76%-3.52%-38.71% 226B
+4.48%+7.33%+30.47%+66.31% 212B
+2.91%+3.10%+18.84%+74.76% 167B
Average +1.36%+4.90%+29.89%+50.69% 377.58B
Weighted average by Cap. +1.50%+5.12%+40.62%+79.19%

Financials

2026 *2027 *
Net sales 11.4B 15.17B 13.31B 12.39B 21.37B 1,449B 21.74B 147B 57.55B 719B 56.93B 55.7B 2,483B 11.89B 15.82B 13.88B 12.93B 22.29B 1,511B 22.67B 153B 60.03B 749B 59.39B 58.1B 2,590B
Net income 1.74B 2.32B 2.04B 1.9B 3.27B 222B 3.32B 22.48B 8.8B 110B 8.71B 8.52B 380B 1.9B 2.53B 2.22B 2.07B 3.56B 242B 3.62B 24.52B 9.6B 120B 9.49B 9.29B 414B
Net Debt 6.91B 9.2B 8.07B 7.52B 12.96B 879B 13.18B 89.18B 34.91B 436B 34.53B 33.79B 1,506B 6.4B 8.52B 7.48B 6.96B 12.01B 814B 12.21B 82.6B 32.33B 404B 31.99B 31.29B 1,395B
Logo Haleon plc
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (29.5%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (22.8%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (17.7%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - vitamins, minerals and food supplements (15.1%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. - respiratory medicines (14.9%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (41.2%), North America (36%), and Asia/Pacific (22.8%).
Employees
24,535
Date Price Change Volume
26-07-29 GBX 380.90 0.00% 837,505
26-07-28 GBX 380.90 +2.89% 29,790,922
26-07-27 GBX 370.20 +1.84% 24,375,691
26-07-24 GBX 363.50 +0.53% 12,865,658
26-07-23 GBX 361.60 -1.18% 15,272,042
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
3.809GBP
Average target price
4.142GBP
Spread / Average Target
+8.75%

Quarterly revenue - Rate of surprise